The first example of a patient with etoricoxib‐induced immune hemolytic anemia

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Transfusion

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1537-2995.2012.03843.xPMID 22882551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-induced immune hemolytic anemia

  2009cited by this paper
• Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug‐induced nonimmunologic protein adsorption

  2009cited by this paper
• Clinical Pharmacokinetic and Pharmacodynamic Profile of Etoricoxib

  2008cited by this paper
• An update on drug-induced immune hemolytic anemia

  2007cited by this paper
• Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin.

  2002cited by this paper
• Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti‐inflammatory drug

  2000cited by this paper
• Drug-induced immune thrombocytopenia: an overview of pathogenesis.

  1999cited by this paper
• Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

  1999cited by this paper
• Diclofenac‐induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug‐dependent antibodies

  1996cited by this paper
• Drug‐induced immune hemolytic anemia

  1992influential reference
• Antigenic determinants responsible for the reactions of drug‐dependent antibodies with blood cells

  1991cited by this paper
• Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites.

  1990cited by this paper
• Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto‐ and/or drug‐dependent antibodies against these cells

  1987cited by this paper
• Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide.

  1984cited by this paper
• Immune hemolytic anemias.

  1971cited by this paper
• The nature of the alpha-methyldopa red-cell antibody.

  1967cited by this paper

• Etoricoxib and its hidden risks: a case-based review of dermatological, hematological, and cardiovascular complications

  2025cites this paper
• Etoricoxib‐induced immune hemolytic anemia: first case presenting acute kidney failure

  2019influential citation
• Exploring the binding dynamics of etoricoxib with human hemoglobin: A spectroscopic, calorimetric, and molecular modeling approach

  2018cites this paper
• Immune Complex Formation Involving Etoricoxib in a Patient with Acute Severe Anemia

  2017cites this paper
• Seizure following the Use of the COX-2 Inhibitor Etoricoxib

  2017cites this paper
• Myths and misconceptions concerning contrast media-induced anaphylaxis: a narrative review

  2017cites this paper
• Variability of Findings in Drug-Induced Immune Haemolytic Anaemia: Experience over 20 Years in a Single Centre

  2015cites this paper
• Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007

  2014cites this paper
• Drug-induced immune hemolytic anemia: the last 30 years of changes

  2014cites this paper